Intrathymic Delivery of MHC Genes Using Recombinant Adenoviruses

  • Ronald Rooke
  • Christophe Benoist
  • Diane Mathis
Part of the Methods in Molecular Biology™ book series (MIMB, volume 134)


Advances in the study of thymic selection have relied heavily on animals that are genetically manipulated either by transgenesis and/or by knock out technology. Besides being costly and time consuming, these methods suffer inherent limitations (reviewed in refs. 1, 2, 3). In an effort to first, complement the existing panoply of methodologies used in the study of thymocyte selection and second, circumvent some of the problems inherent to these methods, we have developed an adenovirus-based vector system to deliver MHC class II genes to the thymic stroma. When injected into MHC class II-deficient animals (IIo) (4), these vectors punctually restore the expression of MHC class II molecules on the surface of transduced thymic stromal cells (5). In turn, the block in T-cell development associated with the absence of MHC class II molecules in these thymi is relieved and significant numbers of mature CD4 single positive thymocytes appear (5). Alternatively, this gene delivery system has also been used to look at positive selection of T cell receptor (TCR) transgenic thymocytes by a known peptide engineered in the invariant chain gene (6). Although variability is seen in the reconstitution of injected animals, this method is a reliable delivery tool for punctual expression of genes in the thymic stroma. The experiments we have carried out indicate that the cortex of the thymus is the main target for MHC class II expression. Here, we will first describe the procedures to make, characterize, and produce high titer stocks of recombinant viruses, followed by the surgical procedure allowing intrathymic delivery of the virus.


Adenovirus Vector Recombinant Virus Virus Stock Transfer Plasmid Thymic Stromal Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mittrücker, H. W., Pfeffer, K., Schmits, R., and Mak, T. W. (1995) T-lymphocyte development and function in gene-targeted mutant mice. Immunol. Rev. 148, 115–150.PubMedCrossRefGoogle Scholar
  2. 2.
    Banks, T. A. and Mucenski, M. L. (1994) Gene targeting of the immune system: the surprises continue. Curr. Opin. Biotechnol. 5, 604–610.PubMedCrossRefGoogle Scholar
  3. 3.
    von Boehmer, H. (1996) CD4/CD8 lineage commitment: back to instruction? J. Exp. Med. 183, 713–715.CrossRefGoogle Scholar
  4. 4.
    Corgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., and Mathis, D. (1991) Mice lacking MHC class II molecules. Cell 66, 1051–1066.CrossRefGoogle Scholar
  5. 5.
    Rooke, R., Waltzinger, C., Benoist, C., and Mathis, D. (1997) Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7, 123–134.PubMedCrossRefGoogle Scholar
  6. 6.
    Nakano, N., Rooke, R., Benoist, C., and Mathis, D. (1997) Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science 275, 678–683.PubMedCrossRefGoogle Scholar
  7. 7.
    Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821–850.PubMedCrossRefGoogle Scholar
  8. 8.
    Harding, C. V. (1995) Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules. Semin. Immunol. 6, 355–360.CrossRefGoogle Scholar
  9. 9.
    Mathis, D. J., Benoist, C., Williams, V. E., Kanter, M., and McDevitt, H. O. (1983) Several mechanisms can account for defective Eα gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA 86, 273–277.CrossRefGoogle Scholar
  10. 10.
    Germain, R. N. and Malissen, B. (1986) Analysis of expression and function of class II major histocompatibility complex encoded molecules by DNA-mediated gene transfer. Ann. Rev. Immunol. 4, 281–315.CrossRefGoogle Scholar
  11. 11.
    Ali, M., Lemoine, N. R., and Ring, C. J. A. (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther. 1, 367–384.PubMedGoogle Scholar
  12. 12.
    Kouskoff, V., Fehling, H. J., Lemeur, M., Benoist, C., Mathis, D. (1993) A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166, 287–291.PubMedCrossRefGoogle Scholar
  13. 13.
    Stratford-Perricaudet, L. D., Levrero, M., Chasse, J. F., Perricaudet, M., and Briand, P. (1990) Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Human Gene Ther. 1, 241–256.CrossRefGoogle Scholar
  14. 14.
    Louis, N., Evelegh, C., and Graham, F. L. (1997) Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233, 423–429.PubMedCrossRefGoogle Scholar
  15. 15.
    Sambrook, J., Fritsch, E. F., and Maniatis, T., eds. (1989) Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.Google Scholar
  16. 16.
    Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365–369.PubMedCrossRefGoogle Scholar
  17. 17.
    Scollay, R., Butcher, E., and Weissman, I. (1980) Thymus cell migration: quantitative studies on the rate of migration of cells from the thymus to the periphery in mice. Eur. J. Immunol. 10, 210–217.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Ronald Rooke
    • 1
  • Christophe Benoist
    • 2
  • Diane Mathis
    • 2
  1. 1.Transgene S. A.StrasbourgFrance
  2. 2.Institut de Genetique et de Biologie Moleculaire et CellulaireStrasbourgFrance

Personalised recommendations